“Emilia Pérez” star Karla Sofía Gascón has set her first project after controversy erupted in January over her past offensive tweets. The Oscar nominee revealed that she will lead “The ...

Karla Sofía Gascón’s racist and Islamaphobic tweets didn’t cast her out of the industry; instead, they elevated her to the status of “both God and the devil.” Per Variety, the ...

Gascón first announced last week that she will co-star in “The Life Lift” with Gallo to journalists in Italy, where she is being celebrated by Turin’s Lovers Film Festival, Europe’s ...

“Emilia Pérez” star Karla Sofía Gascón has set her first project after controversy erupted in January over her past offensive tweets. The Oscar nominee revealed that she will lead “The Life Lift,” a ...

“Emilia Pérez” star Karla Sofía Gascón has set her first project after controversy erupted in January over her past offensive tweets. The Oscar nominee revealed that she will lead “The ...

The 2nd Annual MacGuffin Awards, honoring prop masters in film, television, and short-form, will take place Sept. 13 at the Paramount Theater in Los Angeles. The awards are presented by the ...

The actress said in a statement issued to The Hollywood Reporter after the Oscars in March that she "must be and do better, and correct my past faults, without engaging in more darkness" Emilia ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs. By Gina Kolata and Rebecca Robbins A daily pill may be as ...

1. Introduction: Why the Best Weight Loss Pills of 2025 Matter More Than Ever In 2025, the demand for effective, safe, and science-backed weight loss pills has never been higher. As more people ...

Washington [US], March 22 (ANI): Mexican actress Karla Sofia Gascon has broken her silence after a Twitter storm derailed her Oscar hopes for her role in 'Emilia Perez.' According to Deadline ...

Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered as a once-daily oral pill. The ACHIEVE-1 trial ...